The Stewardship Geek Squad. Disclosure. Objectives (Pharmacist Track) Calling the Stewardship Geek Squad: Integrating Information Technology &

Size: px
Start display at page:

Download "The Stewardship Geek Squad. Disclosure. Objectives (Pharmacist Track) Calling the Stewardship Geek Squad: Integrating Information Technology &"

Transcription

1 SCSHP 2014 Annual Meeting The Stewardship Geek Squad Calling the Stewardship Geek Squad: Integrating Information Technology & Antimicrobial Stewardship Julie Ann Justo, PharmD, MS, BCPS, AAHIVP Clinical Assistant Professor South Carolina College of Pharmacy Antimicrobial Stewardship (AS) Biomedical Informatics Information Technology (IT) informatics.com/sites/healthcareinformatics.com/files/imagecache/100x100/doctornurselaptop_ _smaller.jpg 3. pc.jpg Disclosure I do have a vested interest in or affiliation with the following companies or organizations Cubist Pharmaceuticals: Grant/Research Support Antimicrobial Stewardship Goal: Optimize clinical outcomes and minimize unintended consequences of antimicrobial use Optimal Antimicrobial Use Prospective Audit Formulary Restriction Other Strategies Interaction and Feedback Prior Authorization Education Local guidelines Dose optimization De escalation 1. Dellit TH, et al. Clin Infect Dis 2007; 44: Objectives (Pharmacist Track) Review the importance of clinical informatics in the development of antimicrobial stewardship initiatives in the hospital setting Compare various clinical decision support tools used to interface with electronic medical records Describe how novel rapid diagnostic tests can be integrated into stewardship activities to optimize antimicrobial use Antimicrobial Stewardship Infectious Diseases Society of America and Society of Healthcare Epidemiology of America (IDSA/SHEA) guidelines for developing AS programs specifically comment on technology 1 : Health care information technology in the form of electronic medical records (A III), computer physician order entry (B II), and clinical decision support (B II) can improve antimicrobial decisions through the incorporation of [patient specific] data Dellit TH, et al. Clin Infect Dis 2007; 44:

2 Information Technology (IT) Primarily concerned with application of technology, i.e. computer science 1 Operational IT: Computers, servers, , electronic medical record Research IT: Clinical data warehouse Importance of Clinical Informatics Improves connectivity between patient data and knowledge in order to aid in clinical decision making Training Vocational training Certifications Degrees, e.g. computer science or management information systems 1. Bernstam EV, et al. Acad Med 2009; 84: Biomedical Informatics Interdisciplinary Effort Primarily concerned with storage, retrieval, and optimum use of data, information, and knowledge for problem solving and decision making in biomedicine 1 Computers are tools for manipulating information Focus on applications in a given domain Clinical Informatics (CI) Public Health Informatics Research Informatics Bioinformatics Determines the destination Antimicrobial Stewardship Clinical Informatics Charts the course Steers the ship Information Technology 1. Bernstam EV, et al. Acad Med 2009; 84: Biomedical Informatics Training Interdisciplinary Computer Science Biology Healthcare Most with graduate ±post graduate training Computer savvy, but not = IT support! Or I thought you knew how to navigate! ASP CI I thought you knew how to drive! IT I didn t know we were going off road! Can provide vital expertise for implementing antimicrobial stewardship initiatives (in conjunction with IT) 1. Bernstam EV, et al. Acad Med 2009; 84: content/uploads/2012/04/stoogebike.jpg 2

3 Features of a Successful Clinical Decision Support System (CDSS) 1 Clinical Decision Support Systems (CDSSs) 5. Provides online feedback and documentation within the application 6. Offers evidence based clinical recommendations (emphasis on choice) 7. Fulfills the 6 generic uses: Alerting, interpreting, assisting, critiquing, diagnosing, and managing decision support 8. Adheres to standards for clinical terminology 1. Pestotnik SL, et al. Pharmacotherapy 2005; 25(8): Clinical Decision Support Systems Example of applied clinical informatics Patient Data Evidence based Practices CDSSs Focusing on Antimicrobial Stewardship TheraDoc Software Vendor Logo Safety Surveillor MedMined Hospira Inc. Premier Inc. CareFusion Clinician at the point of care QC PathFinder Sentri7 Allscripts McKesson Vecna Pharmacy OneSource Inc. Allscripts McKesson 1. Kullar R, et al. Clin Infect Dis 2013; 57: Features of a Successful Clinical Decision Support System (CDSS) 1 1. Makes clinician s job easier 2. Includes educational component (providing literature and important caveats) to foster user acceptance 3. Delivers patient specific, pertinent data 5 W s: Who to see? What data? What action? Why act? What to document? 4. Operates in real time CDSSs & Stewardship IDSA/SHEA guidelines 1 also comment: Computer based surveillance can facilitate good stewardship by more efficient targeting of antimicrobial interventions, tracking of antimicrobial resistance patterns, and identification of nosocomial infections and adverse drug events (B II). 1. Pestotnik SL, et al. Pharmacotherapy 2005; 25(8): Dellit TH, et al. Clin Infect Dis 2007; 44:

4 Advantages of CDSSs Most are designed to interface with electronic medical records (EMRs), e.g. EPIC and Cerner Generally have greater capacity for AS specific activities than the EMR alone Alerts Reports Targeted Patient Lists Provide combined data that is typically unavailable without significant daily time and effort Cultures and susceptibilities, current antimicrobial regimens, hepatic and renal function, allergies, etc. Barriers to Implementation & Effectiveness of CDSSs 1,2 Cost $100,000 $500,000 per year per institution Time to implementation Committee approval, e.g. Pharmacy & Therapeutics Waiting in the IT queue or task list Time for maintenance Updates to formulary, clinical practice guidelines, etc. Informatics specialists for more advanced algorithms Integration into clinical workflow Alert fatigue 1. Kullar R, et al. Clin Infect Dis 2013; 57: Njoku JC and Hermsen ED. J Pharm Pract 2010; 23: Real Time Alerts and Reporting Sample of targeted patient list by drug usage: CDSS Implementation for AS Pre /postimplementation study evaluating implementation of a CDSS (TheraDoc) at the Nebraska Medical Center 1 8 alert types utilized, including: Polyantibacterials, redundant anaerobic coverage, drug bug mismatch, vancomycin for CONS or MSSA, no positive cultures Of 10,545 alerts, 30% were actionable overall Significant increase in interventions in the postimplementation period ASP made interventions on 75 92% of actionable alerts Decentralized pharmacists made interventions on 12% of actionable alerts Overall acceptance rate: 88% 1. Hermsen ED, et al. Infect Control Hosp Epidemiol 2009; 84: CDSS Implementation for AS 70% of alerts non actionable due to: No need for intervention (65%) Previously dismissed alert (16%) Alert based on old data (13%) Duplicate alert (5%) Other (0.2%) Authors encouraged the third party vendor to improve the algorithms to minimize alert fatigue 1. Hermsen ED, et al. Infect Control Hosp Epidemiol 2009; 84:

5 CDSSs within the EMR Tools within EPIC 1 : 1. ivents Hour Stop Date 3. IV to PO Interchange 4. Antibiotic Order Forms and Dose Checking Alerts 5. Navigator and Best Practice Alerts 6. Patient Scoring and Monitoring Patient Scoring and Monitoring Custom scoring algorithm to help identify patients with higher priority interventions May significantly improve ASP efficiency Likely requires significantly more time and effort for IT to develop 1. Kullar R, et al. Clin Infect Dis 2013; 57: Kullar TH, et al. Clin Infect Dis 2007; 44: Antibiotic Order Forms Required fields for each order, assists in education and research Stewardship at the point of order verification Rapid Diagnostic Tests (RDTs) 1. Kullar TH, et al. Clin Infect Dis 2007; 44: Navigator and Best Practice Alerts ASP recommendations made as a Best Practice Alert Published evidence provided at the point of care Rapid Diagnostic Tests Novel tests that can significantly me to: Organism identification Susceptibility testing data 1. Kullar TH, et al. Clin Infect Dis 2007; 44: Goff DA, et al. Pharmacotherapy 2012; 32:

6 Rapid Diagnostic Tests Technology Time (h) Trade Name(s) (Manufacturer) Polymerase chain reaction (PCR) , 6* Xpert (Cepheid), FilmArray (Biofire), BD GeneOhm (BD GeneOhm), Progastro Cd (Gen Probe desse), LightCycler SeptiFast Test MGRADE* (Roche Molecular Systems) Peptide nucleic acid fluorescence in situ hybridization (PNA FISH) 1.5 GNR Traffic Light PNA FISH (AdvanDx), Yeast Traffic Light PNA FISH (AdvanDx) PNA FISH Yeast Traffic Light PNA FISH Bacteriophage amplification 5.5 KeyPath MRSA/MSSA Blood Culture (MicroPhage) Nucleic acid 2.5 Verigene (Nanosphere) Loop mediated isothermal amplification (LAMP) Matrix assisted laser desorption ionization time of flight (MALDI TOF) mass spectrometry (MS) 1 illumigene C. difficile (Meridian Bioscience) 0.2 MALDI Biotyper (Bruker Daltonics) VITEK MS (biomérieux) * Direct from blood prior to culture 1. Goff DA, et al. Pharmacotherapy 2012; 32: PNA FISH Overview.png 2. fish tests/yeast traffic light Rapid Diagnostic Tests Microorganisms/Resistance Mechanisms Gram Positive Bacteria Staphylococcus spp.: aureus, epidermidis, lugdunensis Streptococcus spp.: anginosus Group, agalactiae, pneumoniae, pyogenes Enterococcus spp.: faecalis, faecium Clostridium difficile Resistance Mechanisms: meca, vana, vanb Gram Negative Bacteria Escherichia coli Klebsiella pneumoniae Klebsiella oxytoca Pseudomonas aeruginosa Serratia marcescens Resistance Mechanisms: KPC, NDM, CTX M, VIM, IMP, OXA Fungi Candida spp.: albicans, glabrata, krusei, parapsilosis, tropicalis Aspergillus fumigatus Viruses Adenovirus Norovirus Rotavirus 1. Goff DA, et al. Pharmacotherapy 2012; 32: Acinetobacter spp. Proteus spp. Citrobacter spp. Enterobacter spp. Outcomes with PNA FISH for Candida Implementation significantly reduced time to: Identification of C. albicans Median 9.5 h vs. 44 h, p< Median 0.2 d vs. 4 d, p< Targeted therapy 2 Mean 0.6 vs. 2.3 d, p= Culture clearance 2 Median 4 d vs. 5 d, p=0.01 Cost savings estimated at $415 1,837 per patient treated 1 3 Mainly due to decreased drug costs, i.e. switch from echinocandins to fluconazole 1. Forrest GN, et al. J Clin Microbiol 2006; 44: Heil EL, et al. Am J Health Syst Pharm 2012; 69: Alexander BD, et al. Diag Microbiol Infect Dis 2006; 54: FilmArray Blood Culture Identification Panel FilmArray MALDI TOF MS MALDI TOF System 1. FilmArray Blood Culture Identification Panel. Biofire Diagnostics. Sheet FilmArray BCID Panel 0069.pdf Automated Identification & Susceptibility Testing System 6

7 MALDI TOF MS 1. Deposit bacteria or yeast 2. Add matrix solution(s) 3. Analyze result within minutes 1 isolate per spot 48 spots per slide Outcomes with MALDI TOF & ASP in Bloodstream Infections (BSIs) Interven on showed significant in me to: Organism ID (55.9 vs h, p<0.001) Effective therapy (20.4 vs h, p=0.021) Optimal therapy (47.3 vs h, p< 0.001) 1 cartridge = 4 slides = 192 isolates per run 1. Huang AM, et al. Clin Infect Dis 2013; 57: MALDI TOF MS Outcomes with MALDI TOF & ASP in Bloodstream Infections (BSIs) Intervention also showed significant in: 30 day all cause mortality (12.7% vs. 20.3%, p=0.021) Length of ICU stay (8.3 vs d, p=0.014) Recurrence of same BSI (2.0% vs. 5.9%, p=0.038) 1. Huang AM, et al. Clin Infect Dis 2013; 57: Outcomes with MALDI TOF & ASP in Bloodstream Infections (BSIs) Pre post quasi experimental study at University of Michigan Hospitals and Health System Evaluated clinical outcomes in 501 adult patients with BSIs over 3 month periods before and after intervention Intervention: MALDI TOF identification (ID) reported 6:00am 11:30pm Blood subcultured and incubated overnight prior to analysis ASP activities Real time alerts for (+) blood cultures via TheraDoc Recommendations according to local guidelines at time of (1) Gram stain, (2) organism ID, and (3) susceptibility testing results Other Technologies Websites 1 Many ASP resources from leading academic medical center are publicly available Johns Hopkins Health System The Nebraska Medical Center programs/asp Valuable local marketing tool Smartphone apps 2 iphone/ipad or Android Potential educational tool for ID topics 1. Huang AM, et al. Clin Infect Dis 2013; 57: Gauthier TP, et al. Clin Infect Dis 2014; 58: Moodley A, et al. Clin Infect Dis 2013; 57:

8 Summary ASP initiatives should provide clinicians with pertinent patient data and evidence based practices at the point of care Cl and IT specialists are vital members of the stewardship geek squad CDSSs and RDTs offer unique opportunities to optimize antimicrobial therapy and affect patient outcomes ASPs are emerging as ideal models for integrating technology and informatics into healthcare SCSHP 2014 Annual Meeting Calling the Stewardship Geek Squad: Integrating Information Technology & Antimicrobial Stewardship Julie Ann Justo, PharmD, MS, BCPS, AAHIVP Clinical Assistant Professor South Carolina College of Pharmacy 8

MSHP Annual Meeting 11/7/2014

MSHP Annual Meeting 11/7/2014 Using Clinical Decision Support (CDS): Meeting Quality Measures and Beyond Michael D. Kraft, PharmD, BCNSP Clinical Associate Professor University of Michigan College of Pharmacy Assistant Director-Education

More information

BD Phoenix Automated Microbiology System

BD Phoenix Automated Microbiology System BD Phoenix Automated Microbiology System Resistance Detection Workflow Efficiency Analysis and Communication BD Diagnostics 7 Loveton Circle Sparks, MD 115-0999 800.638.8663 www.bd.com/ds CHROMagar is

More information

Bringing the Power to Cerner s PowerChart for Antimicrobial Stewardship

Bringing the Power to Cerner s PowerChart for Antimicrobial Stewardship Clinical Infectious Diseases Advance Access published May 22, 2014 INVITED ARTICLE CLINICAL PRACTICE Ellie J. C. Goldstein, Section Editor Bringing the Power to Cerner s PowerChart for Antimicrobial Stewardship

More information

Computer Decision Support for Antimicrobial Prescribing: Form Follows Function. Matthew Samore, MD University of Utah

Computer Decision Support for Antimicrobial Prescribing: Form Follows Function. Matthew Samore, MD University of Utah Computer Decision Support for Antimicrobial Prescribing: Form Follows Function Matthew Samore, MD University of Utah And it was so typically brilliant of you to have invited an epidemiologist Outline

More information

2013 Indiana Healthcare Provider and Hospital Administrator Multi-Drug Resistant Organism Survey

2013 Indiana Healthcare Provider and Hospital Administrator Multi-Drug Resistant Organism Survey 2013 Indiana Healthcare Provider and Hospital Administrator Multi-Drug Resistant Organism Survey Antibiotic resistance is a global issue that has significant impact in the field of infectious diseases.

More information

Antimicrobial Stewardship for Hospital Acquired Infection Prevention: Focus on C. difficile infection

Antimicrobial Stewardship for Hospital Acquired Infection Prevention: Focus on C. difficile infection Antimicrobial Stewardship for Hospital Acquired Infection Prevention: Focus on C. difficile infection Emi Minejima, PharmD Assistant Professor of Clinical Pharmacy USC School of Pharmacy [email protected]

More information

Infectious Diseases @ EUHM Learning Activities:

Infectious Diseases @ EUHM Learning Activities: Infectious Diseases @ EUHM Learning Activities: Preceptor: Steve Mok, PharmD, BCPS (AQ-ID) Office: EUHM Clinical Pharmacy office, 2 nd fl Peachtree Building Hours: 8:00 17:00 Desk: 404-686-8904 Pager:

More information

healthcare associated infection 1.2

healthcare associated infection 1.2 healthcare associated infection A C T I O N G U I D E 1.2 AUSTRALIAN SAFETY AND QUALITY GOALS FOR HEALTH CARE What are the goals? The Australian Safety and Quality Goals for Health Care set out some important

More information

Practice Spotlight. Florida Hospital Orlando Orlando, FL www.floridahospital.com IN YOUR VIEW, HOW WOULD YOU DEFINE THE IDEAL PHARMACY PRACTICE MODEL?

Practice Spotlight. Florida Hospital Orlando Orlando, FL www.floridahospital.com IN YOUR VIEW, HOW WOULD YOU DEFINE THE IDEAL PHARMACY PRACTICE MODEL? Practice Spotlight Florida Hospital Orlando Orlando, FL www.floridahospital.com Craig Coumbe, R.Ph., M.B.A. Director of Pharmacy Rania El Lababidi, Pharm.D., BCSP (AQ ID), AAHIVP Assistant Director, Clinical

More information

Phase Final Presentation

Phase Final Presentation Phase Final Presentation Research About Antimicrobial Stewardship Program Yuan Zhao Outlines Background Introduction: What is ASP? Purpose of the project Project overview Methods Results Conclusion Limitation

More information

Guidelines for Antimicrobial Stewardship in Hospitals in Ireland. A Strategy for the Control of Antimicrobial Resistance in Ireland

Guidelines for Antimicrobial Stewardship in Hospitals in Ireland. A Strategy for the Control of Antimicrobial Resistance in Ireland A Strategy for the Control of Antimicrobial Resistance in Ireland Guidelines for Antimicrobial Stewardship in Hospitals in Ireland Hospital Antimicrobial Stewardship Working Group Guidelines for Antimicrobial

More information

GUIDELINES EXECUTIVE SUMMARY

GUIDELINES EXECUTIVE SUMMARY GUIDELINES Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship Timothy

More information

Use of computer technology to support antimicrobial stewardship

Use of computer technology to support antimicrobial stewardship 10 Use of computer technology to support antimicrobial stewardship Author: Karin Thursky 10.1 Key points Part 2 Use of computer technology to support antimicrobial stewardship Electronic clinical decision-support

More information

5 Measuring the performance

5 Measuring the performance 5 Measuring the performance of antimicrobial stewardship programs Authors: David Looke and Margaret Duguid 5.1 Key points Part I Measuring the performance of antimicrobial stewardship programs Monitoring

More information

Conflict of Interest Disclosure

Conflict of Interest Disclosure Leveraging Clinical Decision Support for Optimal Medication Management Anne M Bobb, BS Pharm., Director Quality Informatics Children s Memorial Hospital, Chicago IL, February 20, 2012 DISCLAIMER: The views

More information

Decreased Mortality Associated With Prompt Gram Staining of Blood Cultures

Decreased Mortality Associated With Prompt Gram Staining of Blood Cultures Microbiology and Infectious Disease / Timely Gram Staining of Blood Cultures Decreased Mortality Associated With Prompt Gram Staining of Blood Cultures Joan Barenfanger, MD, Donald R. Graham, MD, 2 Lavanya

More information

Clinical Surveillance: Clinical Decision-Support Systems in the Pharmacy Practice Model Initiative

Clinical Surveillance: Clinical Decision-Support Systems in the Pharmacy Practice Model Initiative A Continuing Education Monograph for Pharmacists Clinical Surveillance: Clinical Decision-Support Systems in the Pharmacy Practice Model Initiative Contributors DAVID A. ZILZ, RPH, MS, FASHP A ProCE-publication

More information

Clinical Decision Support

Clinical Decision Support Goals and Objectives Clinical Decision Support What Is It? Where Is It? Where Is It Going? Name the different types of clinical decision support Recall the Five Rights of clinical decision support Identify

More information

University of Louisville Hospital PGY1 Pharmacy Residency Program Summary

University of Louisville Hospital PGY1 Pharmacy Residency Program Summary University of Louisville Hospital PGY1 Pharmacy Residency Program Summary Positions Available: 4 positions, 12 month contract Application Deadline: Early January (see PhORCAS) Requirements: On-site Interview,

More information

MAKING THE BUSINESS CASE FOR ASP: TAKING IT TO THE C-SUITE

MAKING THE BUSINESS CASE FOR ASP: TAKING IT TO THE C-SUITE MAKING THE BUSINESS CASE FOR ASP: TAKING IT TO THE C-SUITE Gary R Kravitz MD FACP FIDSA FSHEA St. Paul Infectious Disease Associates Hospital Epidemiologist/ Director ASP United Hospital, St. Paul, MN

More information

Pharmaceutical Care Lectures. Jay D. Currie, Pharm.D. Fall 2006

Pharmaceutical Care Lectures. Jay D. Currie, Pharm.D. Fall 2006 Pharmaceutical Care Lectures Jay D. Currie, Pharm.D. Fall 2006 History of the development of the pharmaceutical care model clinical pharmacy practice - 1960's move toward "patient-oriented practice" away

More information

Controversies in Hospital Medicine: Antifungal Therapy. Empiric Therapy, Combination Therapy, and the Question of Central Venous Catheters

Controversies in Hospital Medicine: Antifungal Therapy. Empiric Therapy, Combination Therapy, and the Question of Central Venous Catheters Controversies in Hospital Medicine: Antifungal Therapy Empiric Therapy, Combination Therapy, and the Question of Central Venous Catheters Douglas Fish, Pharm.D. Professor of Pharmacy, University of Colorado

More information

AMS on the move: use of electronic medication management prescribed data to inform a mobile application

AMS on the move: use of electronic medication management prescribed data to inform a mobile application AMS on the move: use of electronic medication management prescribed data to inform a mobile application Jessica Del Gigante CEC AMS Forum 4 th September 2015 Agenda 1) Antimicrobial Stewardship (AMS) at

More information

Johns Hopkins Pathology Informatics

Johns Hopkins Pathology Informatics Johns Hopkins Pathology Informatics Joel Saltz, MD, PhD - Director Support to Johns Hopkins Pathology Research in Medical Informatics Research in Computer Science Development of External Software Products

More information

Information Technology Report to Medical Executive Committee

Information Technology Report to Medical Executive Committee April 9, 2013 z Information Technology Report to Medical Executive Committee Contents 1 PACS Selection 1 Successful Implementation of Voice Recognition for Radiologists 2 Cerner PowerChart Ambulatory EHR/PM

More information

Clinical Decision Support (CDS) Options in a CPOE System. Lolita G. White, PharmD Clinical Applications Analyst

Clinical Decision Support (CDS) Options in a CPOE System. Lolita G. White, PharmD Clinical Applications Analyst Clinical Decision Support (CDS) Options in a CPOE System Lolita G. White, PharmD Clinical Applications Analyst Clinical Decision Support Clinical decision support (CDS) systems provide clinicians, staff,

More information

C-Difficile Infection Control and Prevention Strategies

C-Difficile Infection Control and Prevention Strategies C-Difficile Infection Control and Prevention Strategies Adrienne Mims, MD MPH VP, Chief Medical Officer [email protected] 1/18/2016 1 Disclosure This educational activity does not have commercial

More information

The role of MALDI-TOF in Clinical Microbiology, Including the Rapid Identification of Isolates from Positive Blood Cultures

The role of MALDI-TOF in Clinical Microbiology, Including the Rapid Identification of Isolates from Positive Blood Cultures The role of MALDI-TOF in Clinical Microbiology, Including the Rapid Identification of Isolates from Positive Blood Cultures Steve Davies Bacteriology Dept Manager Northern General Hospital Sheffield Teaching

More information

How To Treat Mrsa From A Dead Body

How To Treat Mrsa From A Dead Body HUSRES Annual Report 2012 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara 2013 1 The basis of this HUSRES 2012 report is the HUSLAB/Whonet database 2012, which contains susceptibility data on

More information

Microcyn Technology. Life-Altering Advance in Tissue Care

Microcyn Technology. Life-Altering Advance in Tissue Care Microcyn Technology Life-Altering Advance in Tissue Care The patented Microcyn Technology mimics the same oxychlorine composition as that manufactured by neutrophils in the body s immune system. Neutrophils

More information

ELECTRONIC MEDICAL RECORDS (EMR)

ELECTRONIC MEDICAL RECORDS (EMR) ELECTRONIC MEDICAL RECORDS (EMR) SAUDI BOARD FOR COMMUNITY MEDICINE FIRST PART - FIRST SEMESTER (FALL 2010) COURSE SBCM 002: MEDICAL INFORMATICS Osama Alswailem MD MA Medical Record function 1. It s a

More information

CANDIDA INFECTIONS - TREATMENT GUIDELINES IN ADULT

CANDIDA INFECTIONS - TREATMENT GUIDELINES IN ADULT Page 1 of 6 TITLE: PATIENTS CANDIDA INFECTIONS - TREATMENT GUIDELINES IN ADULT GUIDELINES: These are the 2011 Guidelines for the Treatment of Candida species infections in adult patients. These recommendations

More information

Antimicrobial Resistance and Human Health

Antimicrobial Resistance and Human Health Antimicrobial Resistance and Human Health Dearbháile Morris, Discipline of Bacteriology, School of Medicine, National University of Ireland, Galway The microbial world The is a gene Talk cloud in a The

More information

Evolution of a Closed Loop Medication Use Process

Evolution of a Closed Loop Medication Use Process Evolution of a Closed Loop Medication Use Process Paul J. Vitale, Pharm.D. [email protected] Vice President and Chief Pharmacy Officer The Mercy Medical Center Baltimore, Maryland Agenda Hospital Background

More information

HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi

HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara, 2/2011 1 The basis of this HUSRES 2010 report is the HUSLAB/Whonet database 2010, which contains susceptibility data

More information

SAMPLE ANTIMICROBIAL STEWARDSHIP POLICY

SAMPLE ANTIMICROBIAL STEWARDSHIP POLICY SAMPLE ANTIMICROBIAL STEWARDSHIP POLICY FOR A LOCAL HEALTH DISTRICT OR NETWORK Purpose of this document The development of an official policy for Antimicrobial Stewardship (AMS) is a fundamental step towards

More information

BacT/Alert: an Automated Colorimetric Microbial Detection System

BacT/Alert: an Automated Colorimetric Microbial Detection System JOURNAL OF CLINICAL MICROBIOLOGY, JUlY 199, P. 168-1612 Vol. 28, No. 7 95-1137/9/7168-5$2./ Copyright 199, American Society for Microbiology BacT/Alert: an Automated Colorimetric Microbial Detection System

More information

HIMSS Electronic Health Record Definitional Model Version 1.0

HIMSS Electronic Health Record Definitional Model Version 1.0 HIMSS Electronic Health Record Definitional Model Version 1.0 Prepared by HIMSS Electronic Health Record Committee Thomas Handler, MD. Research Director, Gartner Rick Holtmeier, President, Berdy Systems

More information

National Quality Forum Safe Practices for Better Healthcare

National Quality Forum Safe Practices for Better Healthcare National Quality Forum Safe Practices for Better Healthcare UCLA Health System advocates the National Quality Forum (NQF) endorsed safe practices.this set of safe Practices encompasses 34 practices that

More information

DISCLAIMER OBJECTIVES IV ROBOTICS IV ROBOTICS

DISCLAIMER OBJECTIVES IV ROBOTICS IV ROBOTICS DISCLAIMER NEW PHARMACY TECHNOLOGY AND AUTOMATION UPDATE Christopher R. Fortier, PharmD Manager, Pharmacy Support Services Clinical Assistant Professor Medical University of South Carolina Charleston,

More information

REAL-TIME INTELLIGENCE FOR FASTER PATIENT INTERVENTIONS. MICROMEDEX 360 Care Insights. Real-Time Patient Intervention

REAL-TIME INTELLIGENCE FOR FASTER PATIENT INTERVENTIONS. MICROMEDEX 360 Care Insights. Real-Time Patient Intervention REAL-TIME INTELLIGENCE FOR FASTER PATIENT INTERVENTIONS MICROMEDEX 360 Care Insights Real-Time Patient Intervention Real-Time Intelligence for Fast Patient Interventions At your patient s side, developments

More information

How To Treat Mrsa In Finnish

How To Treat Mrsa In Finnish HUSRES Annual Report 2013 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara 2014 1 The basis of this HUSRES 2013 report is the HUSLAB/Whonet database 2013, which contains susceptibility data on

More information

Optimizing Antimicrobial Susceptibility Test Reporting

Optimizing Antimicrobial Susceptibility Test Reporting JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2011, p. S15 S19 0095-1137/11/$12.00 doi:10.1128/jcm.00712-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. VOL. 49, NO. 9 SUPPL. Optimizing

More information

Medical Informatics: Why Care? Kevin Chang, MD, MS Scott and White Healthcare 8/13/2013

Medical Informatics: Why Care? Kevin Chang, MD, MS Scott and White Healthcare 8/13/2013 Medical Informatics: Why Care? Kevin Chang, MD, MS Scott and White Healthcare 8/13/2013 About me Education and Training 1998 2004 UMKC School of Medicine, BA Chemistry, MD 2004 2008 UTMB Austin IM Resident

More information

Etiology and treatment of chronic bacterial prostatitis the Croatian experience

Etiology and treatment of chronic bacterial prostatitis the Croatian experience Etiology and treatment of chronic bacterial prostatitis the Croatian experience Višnja Škerk University Hospital for Infectious Diseases "Dr. Fran Mihaljevic" Zagreb Croatia Milano, Malpensa, 14 Nov 2008

More information

Community Oncology 2.0 Information Technology A Practical Guide: Navigating from Today to Tomorrow

Community Oncology 2.0 Information Technology A Practical Guide: Navigating from Today to Tomorrow Community Oncology 2.0 Information Technology A Practical Guide: Navigating from Today to Tomorrow Lucio Gordan, MD Florida Cancer Specialists Medical Informatics and Integrated Clinical Services COA National

More information

Patients Receive Recommended Care for Community-Acquired Pneumonia

Patients Receive Recommended Care for Community-Acquired Pneumonia Patients Receive Recommended Care for Community-Acquired Pneumonia For New Jersey to be a state in which all people live long, healthy lives. DSRIP LEARNING COLLABORATIVE PRESENTATION The Care you Trust!

More information

California Antimicrobial Stewardship Program Initiative & Clostridium difficile Infection (CDI) Project

California Antimicrobial Stewardship Program Initiative & Clostridium difficile Infection (CDI) Project 1 California Antimicrobial Stewardship Program Initiative & Clostridium difficile Infection (CDI) Project Hospital Association of Southern California Conference February 26, 2015 Vicki Keller, RN,MSN,CIC

More information

Translating Evidence to Safer Care Patient Safety Research Introductory Course Session 7 Albert W Wu, MD, MPH Former Senior Adviser, WHO Professor of Health Policy & Management, Johns Hopkins Bloomberg

More information

Why Do Some Antibiotics Fail?

Why Do Some Antibiotics Fail? Why Do Some Antibiotics Fail? Patty W. Wright, M.D. April 2010 Objective To outline common reasons why antibiotic therapy is not successful and how this can be avoided. And to teach you a little bit about

More information

Instructions for Completion of Primary Bloodstream Infection (BSI) Form (CDC 57.108)

Instructions for Completion of Primary Bloodstream Infection (BSI) Form (CDC 57.108) Instructions for Completion of Primary Bloodstream Infection (BSI) Form (CDC 57.108) Facility ID Event # Patient ID Social Security # Secondary ID Medicare # Patient name Gender Date of Birth Ethnicity

More information

PGY-2 ONCOLOGY PHARMACY RESIDENCY

PGY-2 ONCOLOGY PHARMACY RESIDENCY PGY-2 ONCOLOGY PHARMACY RESIDENCY Program Description and Requirements Providence Health System (PAMC) in Anchorage consists of 394 acute care beds and is part of an integrated health system including

More information

Thermo Scientific VersaTREK. Automated Microbial Detection System. Value through versatility, flexibility and. excellence in recovery

Thermo Scientific VersaTREK. Automated Microbial Detection System. Value through versatility, flexibility and. excellence in recovery Thermo Scientific VersaTREK Automated Microbial Detection System Value through versatility, flexibility and excellence in recovery The ultimate in versatility: four tests, one platform Faster results,

More information

HUSRES Annual Report 2008 Martti Vaara. www.huslab.fi www.intra.hus.fi

HUSRES Annual Report 2008 Martti Vaara. www.huslab.fi www.intra.hus.fi HUSRES Annual Report 2008 Martti Vaara www.huslab.fi www.intra.hus.fi The basis of this HUSRES 2008 report is the HUSLAB/Whonet database 2008, which contains susceptibility data on about 180.000 bacteria

More information

Information Technology Report to Medical Executive Committee

Information Technology Report to Medical Executive Committee May 13, 2014 z Information Technology Report to Medical Executive Committee Contents 1 McKesson Cardiology PACS 1 Mammography Reporting System (MRS) 1 Ambulatory Project Update 2 Cerner Patient Portal

More information

Evolving role of pharmacists in a patient centric care model

Evolving role of pharmacists in a patient centric care model Evolving role of pharmacists in a patient centric care model Priyesh G. Patel, Pharm.D., MBA Chief Pharmacy Officer Providence Health & Services Oregon Objective Identify and understand workforce competencies

More information

Opportunities for Evidence-based Clinical Decision Support Systems: An Application for Oncology. BPM Roundtable Eindhoven University of Technology

Opportunities for Evidence-based Clinical Decision Support Systems: An Application for Oncology. BPM Roundtable Eindhoven University of Technology Opportunities for Evidence-based Clinical Decision Support Systems: An Application for Oncology BPM Roundtable Eindhoven University of Technology 5/11/2012 Dr. Yaron Denekamp CMIO, Hospital Division, Clalit

More information

Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs

Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs Journal of Antimicrobial Chemotherapy (2006) 57, 326 330 doi:10.1093/jac/dki463 Advance Access publication 29 December 2005 Adjustment of antibiotic treatment according to the results of blood cultures

More information

Disclosure. Meaningful use 2009. Objectives. Meaningful use. Fundamentals of Transitions of Care (TOC)

Disclosure. Meaningful use 2009. Objectives. Meaningful use. Fundamentals of Transitions of Care (TOC) 47 th Annual Meeting August 2-4, 2013 Orlando, FL Fundamentals of Transitions of Care (TOC) Rebecca R. Prevost, B.S., Pharm.D., PSO Medication Safety Officer Florida Hospital Disclosure I do not have a

More information

Fungal Infection in Total Joint Arthroplasty. Dr.Wismer Dr.Al-Sahan

Fungal Infection in Total Joint Arthroplasty. Dr.Wismer Dr.Al-Sahan Fungal Infection in Total Joint Arthroplasty Dr.Wismer Dr.Al-Sahan Delayed Reimplantation Arthroplasty for Candidal Prosthetic Joint Infection: A Report of 4 Cases and Review of the Literature David M.

More information

Use of the BacT/Alert Blood Culture System for Culture of Sterile Body Fluids Other than Blood

Use of the BacT/Alert Blood Culture System for Culture of Sterile Body Fluids Other than Blood JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1998, p. 3273 3277 Vol. 36, No. 11 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Use of the BacT/Alert Blood Culture

More information

Mona Osman MD, MPH, MBA

Mona Osman MD, MPH, MBA Mona Osman MD, MPH, MBA Objectives To define an Electronic Medical Record (EMR) To demonstrate the benefits of EMR To introduce the Lebanese Society of Family Medicine- EMR Reality Check The healthcare

More information

Surveillance cultures PRO. Kurt Espersen ICU 4131 Rigshospitalet Copenhagen

Surveillance cultures PRO. Kurt Espersen ICU 4131 Rigshospitalet Copenhagen Kurt Espersen ICU 4131 Rigshospitalet Copenhagen Difficult to Diagnose Systemic Candidal Infection Immunsuppression in critically ill patients Frequent manifestation of fungus in ICU Fungi were isolated

More information

National Quality Forum (NQF) Endorsed Set of 34 Safe Practices*

National Quality Forum (NQF) Endorsed Set of 34 Safe Practices* NQF Endorsed Set of Safe Practices (released 2009) 1. Leadership Structures and Systems Leadership structures and systems must be established to ensure that there is organization-wide awareness of patient

More information

Course Curriculum for Master Degree in Clinical Pharmacy

Course Curriculum for Master Degree in Clinical Pharmacy Course Curriculum for Master Degree in Clinical Pharmacy The Master Degree in Clinical Pharmacy is awarded by the Faculty of Graduate studies at Jordan University of Science and Technology (JUST) upon

More information

ANTIBIOTICS IN SEPSIS

ANTIBIOTICS IN SEPSIS ANTIBIOTICS IN SEPSIS Jennifer Curello, PharmD, BCPS Clinical Pharmacist, Infectious Diseases Antimicrobial Stewardship Program Ronald Reagan UCLA Medical Center October 27, 2014 The power of antibiotics

More information

HUSRES Annual Report 2015

HUSRES Annual Report 2015 HUSRES Annual Report 2015 1 This report is based on the HUSLAB/Whonet database 2015, which contains data on more than 190.000 microbes. EUCAST 2015 clinical breakpoints have mainly been used. The doses

More information

Specialty Pharmacy Definition

Specialty Pharmacy Definition Isn t All of Special? Developing Services Presented to: 2015 ICHP Annual Meeting Presented on: September 10, 2015 Presented by: Lana Gerzenshtein, Pharm.D., BCPS The speaker has no conflicts of interest

More information

BD Modified CNA Agar BD Modified CNA Agar with Crystal Violet

BD Modified CNA Agar BD Modified CNA Agar with Crystal Violet INSTRUCTIONS FOR USE READY-TO-USE PLATED MEDIA PA-255082.02 Rev.: June 2003 BD Modified CNA Agar BD Modified CNA Agar with Crystal Violet INTENDED USE BD Modified CNA Agar is a selective medium for the

More information

Hospital pharmacists as part of the Drug & Therapeutics Committee I

Hospital pharmacists as part of the Drug & Therapeutics Committee I Hospital pharmacists as part of the Drug & Therapeutics Committee I EAHP Academy Seminar 20 May, Belgrade Serbia Mag. Gunar Stemer Vienna General Hospital, Pharmacy Department Nothing to disclose. EAHP

More information

APIC Position Paper: The Importance of Surveillance Technologies in the Prevention of Healthcare-Associated Infections (HAIs)

APIC Position Paper: The Importance of Surveillance Technologies in the Prevention of Healthcare-Associated Infections (HAIs) 1275 K Street, NW, Suite 1000 Washington, DC 20005-4006 Phone: 202/789-1890 Fax: 202/789-1899 [email protected] www.apic.org APIC Position Paper: The Importance of Surveillance Technologies in the Prevention

More information

APPENDIX B: UWHC SURGICAL ANTIMICROBIAL PROPHYLAXIS GUIDELINES

APPENDIX B: UWHC SURGICAL ANTIMICROBIAL PROPHYLAXIS GUIDELINES APPENDIX B: UWHC SURGICAL ANTIMICROBIAL PROPHYLAXIS GUIDELINES Principles of prophylaxis 1) Use antimicrobials for surgical procedures where prophylactic antimicrobials have been found to be beneficial.

More information

Helsingin ja Uudenmaan alueen herkkyystilastoja 2004. www.huslab.fi www.intra.hus.fi

Helsingin ja Uudenmaan alueen herkkyystilastoja 2004. www.huslab.fi www.intra.hus.fi Helsingin ja Uudenmaan alueen herkkyystilastoja 2004 www.huslab.fi www.intra.hus.fi Staph. aureus 2004 (%R+I) Pus and blood isolates at six hospitals (M,T,L,K,N,Ma) in Helsinki University Central Hospital,

More information

PGY-1 PHARMACY RESIDENCY

PGY-1 PHARMACY RESIDENCY PGY-1 PHARMACY RESIDENCY PGY-1 Match Number: 135413 Program Description and Requirements Providence Health System (PAMC) in Anchorage consists of 394 acute care beds and is part of an integrated health

More information

Aims and content of the Electronic Medical Records in Primary Care: A different approach

Aims and content of the Electronic Medical Records in Primary Care: A different approach Aims and content of the Electronic Medical Records in Primary Care: A different approach Dr Dimitris Kounalakis, General Practitioner, Research Associate, Medical School, University of Crete Electronic

More information

ANTIBIOTIC RESISTANCE THREATS. in the United States, 2013

ANTIBIOTIC RESISTANCE THREATS. in the United States, 2013 ANTIBIOTIC RESISTANCE THREATS in the United States, 2013 TABLE OF CONTENTS Foreword... 5 Executive Summary.... 6 Section 1: The Threat of Antibiotic Resistance... 11 Introduction.... 11 National Summary

More information

Accountable Care Organizations and Patient-Centered Medical Homes

Accountable Care Organizations and Patient-Centered Medical Homes Emerging Topics in Healthcare Reform Accountable Care Organizations and Patient-Centered Medical Homes Janssen Pharmaceuticals, Inc. Accountable Care Organizations and Patient-Centered Medical Homes The

More information

NIAID Genomics and Bioinformatics Programs

NIAID Genomics and Bioinformatics Programs NIAID Genomics and Bioinformatics Programs Vivien G. Dugan, PhD Office of Genomics and Advanced Technologies (OGAT) Division of Microbiology and Infectious Diseases NIAID, NIH, DHHS [email protected]

More information